Resources

March 25, 2021
Physicians and hospitals play a critical role in biosimilar adoption. This paper highlights the importance of examining ways to remove obstacles that may discourage providers from utilizing lower-cost biosimilars with their patients.
February 22, 2021
This paper examines the challenges to market sustainability for generic and biosimilar medicines that have cleared the regulatory and patent hurdles to obtain FDA approval and launch into the U.S. market.
biosimilars news january 2021
February 9, 2021
January's newsletter with the latest updates in the biosimilars industry including policy movement, educational resources and upcoming events.
world cancer day
February 4, 2021
On World Cancer Day, we pause to recognize the toll cancer takes on patients and ways generics and biosimilars are easing the financial burden.
biosimilars news december 2020
January 12, 2021
December's newsletter with the latest updates in the biosimilars industry including policy movement, educational resources and upcoming events.
biosimilars facts
December 22, 2020
A biosimilar is a medicine that is highly similar to a brand biologic medicine, providing the same treatment benefits.

Recent Tweets

Jeni from California found out she had pancolitis a few years ago. After trying different treatment options, she found a biosimilar that let her live her life again for $0 out-of-pocket costs.

Listen to her story: https://biosimilarscouncil.org/resource/biosimilar-patient-stories-jeni/

#Biosimilars #PatientStories

Load More...